case library / market entry and sizing
Veltra Pharma: Clarion launch
A medium to hard market entry and sizing case, interviewer-led, built for live practice with an AI interviewer that grades like a coach.
- Market entry ev
- interviewer-led
- medium to hard
- ~30 min
- 1 exhibit
Our client is Veltra Pharma, a US-based pharmaceutical company that has developed a preventative treatment for chronic migraines called Clarion. It's been in development for years, and management is deciding whether to roll it out to the US market. The addressable market is large, roughly one in seven US adults experiences migraines, and in some segments it's closer to one in five. Two important facts: Clarion went through a lengthy, delayed FDA testing process before approval, and as a result it will come off patent in just a few years. Two questions for today: one, how would you determine whether Clarion will be profitable? And two, all things considered, should Veltra go ahead with the launch?
What happens when you run it live
Your interviewer holds answers to 5 clarifying questions candidates usually ask, so opening the case correctly gets rewarded. The case unfolds over 6 phases, with 1 exhibit handed to you at the right moments. You structure, do the math out loud, and close with a recommendation. Then you get a graded report across structure, quant, insight, synthesis, and communication, with the specific moments that cost you points. The exhibits, numbers, and answer key stay inside the live session, the way a real interviewer keeps the case packet on their side of the table.
How to approach a market entry and sizing case
Market entry cases ask whether a client should enter a new market, geography, or segment, and usually make you size the opportunity before you judge it. Expect a sizing funnel: population or install base, filtered by addressable share, adoption, price, and frequency.
The classic traps are units and time frame. State the unit of every number you produce, and say whether it is annual or one-time. After the math, the case turns to entry economics and risk: how to enter, what it costs to compete, and how incumbents respond. A number without a so-what is a wasted calculation.
Run Veltra Pharma: Clarion launch live, free. About 30 minutes, graded in the same sitting.
Start practicing freefree · no card · graded in minutes